Low-dose or -number of BCG in non-muscle invasive bladder cancer: updated systematic review and meta-analysis.

Saved in:
Bibliographic Details
Title: Low-dose or -number of BCG in non-muscle invasive bladder cancer: updated systematic review and meta-analysis.
Authors: Kawada T; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria.; Department of Urology, Okayama University Graduate School of Medicine, Dentistry & Pharmaceutical Sciences, Okayama, 700-8530, Japan., Yanagisawa T; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria.; Department of Urology, The Jikei University School of Medicine, Tokyo, 105-8471, Japan., Bekku K; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria.; Department of Urology, Okayama University Graduate School of Medicine, Dentistry & Pharmaceutical Sciences, Okayama, 700-8530, Japan., Laukhtina E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria.; Institute for Urology & Reproductive Health, Sechenov University, Moscow, 119435, Russia., Deimling MV; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria.; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, 20251, Germany., Majdoub M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria.; Department of Urology, Hillel Yaffe Medical Center, Hadera, 3820302, Israel., Chlosta M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria.; Department of Urology, Jagiellonian University Medical College, Cracow, 31-008, Poland., Pradere B; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria.; Department of Urology UROSUD, La Croix Du Sud Hospital, Quint Fonsegrives, 31130, France., Babjuk M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria.; Department of Urology, Second Faculty of Medicine of Charles University, University Hospital Motol, Prague, 150 06, Czech Republic., Gontero P; Urology Unit, Department of Surgical Sciences, University of Turin, Turin, 10124, Italy., Moschini M; Department of Urology, IRCCS San Raffaele Hospital & Vita-Salute San Raffaele University, Milan, 20132, Italy., Araki M; Department of Urology, Okayama University Graduate School of Medicine, Dentistry & Pharmaceutical Sciences, Okayama, 700-8530, Japan., Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria.; Institute for Urology & Reproductive Health, Sechenov University, Moscow, 119435, Russia.; Division of Urology, Department of Special Surgery, The University of Jordan, Amman, 11942, Jordan.; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.; Department of Urology, Second Faculty of Medicine, Charles University, Prague, 150 06, Czech Republic.; Department of Urology, Weill Cornell Medical College, New York, NY 1300, USA.; Karl Landsteiner Institute of Urology & Andrology, Vienna, 1090, Austria.
Source: Immunotherapy [Immunotherapy] 2023 Aug; Vol. 15 (12), pp. 933-943. Date of Electronic Publication: 2023 Jul 06.
Publication Type: Meta-Analysis; Systematic Review; Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101485158 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1750-7448 (Electronic) Linking ISSN: 1750743X NLM ISO Abbreviation: Immunotherapy Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1750-7448
DOI:10.2217/imt-2022-0309